Strong Industry Position Propeller Health specializes in digital health solutions for respiratory conditions and has established partnerships with major pharmaceutical companies like Novartis, highlighting opportunities to expand digital therapy integrations and OEM collaborations in respiratory care.

Recent Investment & Growth With a recent $21.5 million funding round led by 3M Ventures and a successful Series C financing, Propeller Health demonstrates significant investor confidence, indicating potential for scaling sales efforts and expanding into new markets within digital respiratory health.

Partnerships & Collaborations Existing collaborations with healthcare providers and pharmaceutical companies suggest opportunities to deepen integrations, leverage data-driven adherence solutions, and build comprehensive remote monitoring services for chronic respiratory patients.

Market Trends & Demand Growing emphasis on remote care, adherence, and continuous monitoring in respiratory health creates a demand for Propeller’s digital platform, providing sales prospects in healthcare systems, payers, and device manufacturers seeking innovative digital solutions.

Operational Expansion Despite the company's ceasing direct operations, Resmed's retention of Propeller’s assets and brand opens avenues for joint ventures, licensing, or white-labeling opportunities with other healthtech providers seeking to expand their respiratory digital health offerings.